Immunogen reported $-61053000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Amgen AMGN:US $ 2176M 324M
Astellas Pharma 4503:JP Y 33147M 46832M
AstraZeneca AZN:LN 44.27B 22.58B
Bluebird Bio BLUE:US $ -107.4M 12.95M
Bristol Myers Squibb BMY:US $ 2590M 37M
Cerulean Pharma CERU:US $ -8400450 1.14M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Emergent Biosolutions EBS:US $ -72M 78.4M
Exelixis EXEL:US $ 83.71M 0.46M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Immunogen IMGN:US $ -61.05M 38.2M
Intrexon XON:US $ -24.16M 6.27M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Novartis NVS:US $ 2228M 624M
Pfizer PFE:US $ 12102M 2229M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Seattle Genetics SGEN:US $ -133.11M 0.06M